Healthcare -
Biotechnology - NASDAQ - US
$ 15.49
-7.91 %
$ 475 M
Market Cap
-2.56
P/E
ANAB - OPERATING EXPENSES
Operating Expenses ANAB - AnaptysBio, Inc.
182 M
LAST VALUE
23.01%
2 YEAR CAGR
20.41%
5 YEAR CAGR
32.64%
10 YEAR CAGR